scholarly journals Gut Microbiota for Health: How Can Diet Maintain A Healthy Gut Microbiota?

Nutrients ◽  
2020 ◽  
Vol 12 (11) ◽  
pp. 3596
Author(s):  
Cinzia Ferraris ◽  
Marina Elli ◽  
Anna Tagliabue
Keyword(s):  
Gut Microbiota ◽  
Intestinal Tract ◽  
Human Intestinal Tract

The human intestinal tract is colonized by a resilient integrated ecosystem represented by a complex consortium of trillions of microbes [...]

scholarly journals Probiotics, Prebiotics, and Synbiotics: Gut and Beyond

2012 ◽  
Vol 2012 ◽  
pp. 1-16 ◽  
Author(s):  
Usha Vyas ◽  
Natarajan Ranganathan
Keyword(s):  
Gut Microbiota ◽  
Intestinal Microbiota ◽  
Intestinal Tract ◽  
Gastric Ulcers ◽  
Colon Cancers ◽  
Bowel Diseases ◽  
Health And Disease ◽  
The Individual ◽  
And Control ◽  
Human Intestinal Tract

The human intestinal tract has been colonized by thousands of species of bacteria during the coevolution of man and microbes. Gut-borne microbes outnumber the total number of body tissue cells by a factor of ten. Recent metagenomic analysis of the human gut microbiota has revealed the presence of some 3.3 million genes, as compared to the mere 23 thousand genes present in the cells of the tissues in the entire human body. Evidence for various beneficial roles of the intestinal microbiota in human health and disease is expanding rapidly. Perturbation of the intestinal microbiota may lead to chronic diseases such as autoimmune diseases, colon cancers, gastric ulcers, cardiovascular disease, functional bowel diseases, and obesity. Restoration of the gut microbiota may be difficult to accomplish, but the use of probiotics has led to promising results in a large number of well-designed (clinical) studies. Microbiomics has spurred a dramatic increase in scientific, industrial, and public interest in probiotics and prebiotics as possible agents for gut microbiota management and control. Genomics and bioinformatics tools may allow us to establish mechanistic relationships among gut microbiota, health status, and the effects of drugs in the individual. This will hopefully provide perspectives for personalized gut microbiota management.

scholarly journals Bioavailability Based on the Gut Microbiota: a New Perspective

2020 ◽  
Vol 84 (2) ◽  
Author(s):  
Feng Zhang ◽  
Fang He ◽  
Li Li ◽  
Lichun Guo ◽  
Bin Zhang ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
Intestinal Tract ◽  
Circulatory System ◽  
Target Cells ◽  
Chinese Medicines ◽  
Effective Strategies ◽  
Substantial Discrepancy ◽  
New Perspective ◽  
Human Intestinal Tract

SUMMARY The substantial discrepancy between the strong effects of functional foods and various drugs, especially traditional Chinese medicines (TCMs), and the poor bioavailability of these substances remains a perplexing problem. Understanding the gut microbiota, which acts as an effective bioreactor in the human intestinal tract, provides an opportunity for the redefinition of bioavailability. Here, we discuss four different pathways associated with the role of the gut microbiota in the transformation of parent compounds to beneficial or detrimental small molecules, which can enter the body’s circulatory system and be available to target cells, tissues, and organs. We further describe and propose effective strategies for improving bioavailability and alleviating side effects with the help of the gut microbiota. This review also broadens our perspectives for the discovery of new medicinal components.

scholarly journals Microbial Metabolites in Colorectal Cancer: Basic and Clinical Implications

Metabolites ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. 159
Author(s):  
Yao Peng ◽  
Yuqiang Nie ◽  
Jun Yu ◽  
Chi Chun Wong
Keyword(s):  
Colorectal Cancer ◽  
Gut Microbiota ◽  
Cancer Diagnosis ◽  
Intestinal Tract ◽  
Clinical Applications ◽  
Diagnosis And Treatment ◽  
Clinical Implications ◽  
Microbial Metabolites ◽  
Colorectal Tumorigenesis ◽  
Technology Studies

Colorectal cancer (CRC) is one of the leading cancers that cause cancer-related deaths worldwide. The gut microbiota has been proved to show relevance with colorectal tumorigenesis through microbial metabolites. By decomposing various dietary residues in the intestinal tract, gut microbiota harvest energy and produce a variety of metabolites to affect the host physiology. However, some of these metabolites are oncogenic factors for CRC. With the advent of metabolomics technology, studies profiling microbiota-derived metabolites have greatly accelerated the progress in our understanding of the host-microbiota metabolism interactions in CRC. In this review, we briefly summarize the present metabolomics techniques in microbial metabolites researches and the mechanisms of microbial metabolites in CRC pathogenesis, furthermore, we discuss the potential clinical applications of microbial metabolites in cancer diagnosis and treatment.

scholarly journals Interplay between the Gut Microbiota and Inflammatory Mediators in the Development of Colorectal Cancer

Cancers ◽  
2021 ◽  
Vol 13 (4) ◽  
pp. 734
Author(s):  
Gwangbeom Heo ◽  
Yunna Lee ◽  
Eunok Im
Keyword(s):  
Colorectal Cancer ◽  
Gut Microbiota ◽  
Inflammatory Mediators ◽  
Tumor Metastasis ◽  
Intestinal Tract ◽  
Fecal Microbiota Transplantation ◽  
Fecal Microbiota ◽  
Therapeutic Interventions ◽  
Potential Therapeutic Target ◽  
Necrosis Factor

Inflammatory mediators modulate inflammatory pathways during the development of colorectal cancer. Inflammatory mediators secreted by both immune and tumor cells can influence carcinogenesis, progression, and tumor metastasis. The gut microbiota, which colonize the entire intestinal tract, especially the colon, are closely linked to colorectal cancer through an association with inflammatory mediators such as tumor necrosis factor, nuclear factor kappa B, interleukins, and interferons. This association may be a potential therapeutic target, since therapeutic interventions targeting the gut microbiota have been actively investigated in both the laboratory and in clinics and include fecal microbiota transplantation and probiotics.

scholarly journals Cloudy Apple Juice Fermented by Lactobacillus Prevents Obesity Via Modulating Gut Microbiota and Protecting Intestinal Tract Health

Nutrients ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 971
Author(s):  
Mengzhen Han ◽  
Meina Zhang ◽  
Xiaowei Wang ◽  
Xue Bai ◽  
Tianli Yue ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
High Fat Diet ◽  
Apple Juice ◽  
Intestinal Tract ◽  
Lipid Level ◽  
Blood Lipid ◽  
Obese Mice ◽  
Research Findings ◽  
Gut Microbiota Composition ◽  
Blood Lipid Levels

Obesity and hyperglycemia are two serious chronic diseases that are increasing in incidence worldwide. This research aimed to develop a fermented cloudy apple juice with good hyperglycemia intervention activities. Here, cloudy apple juice (CAJ), cloudy apple juice rich in polyphenols (CAJP) and fermented cloudy apple juice rich in polyphenols (FCAJP) were prepared sequentially, and then the effects of the three apple juices on weight, lipid level, gut microbiota composition and intestinal tract health were evaluated for obese mice induced by a high-fat diet. The research findings revealed that the FCAJP showed potential to inhibit the weight gain of mice, reduce fat accumulation, and regulate the blood lipid levels of obese mice by decreasing the ratio of the Firmicutes/Bacteroidotas, improving the Sobs, Ace, and Chao indexes of the gut microbiota and protecting intestinal tract health. In addition, the FCAJP augmented the abundance of Akkermansia and Bacteroides, which were positively related to SCFAs in cecal contents. This study inferred that FCAJP could be developed as a healthy food for preventing obesity and hyperglycemia.

scholarly journals A diet high in sugar and fat influences neurotransmitter metabolism and then affects brain function by altering the gut microbiota

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Yinrui Guo ◽  
Xiangxiang Zhu ◽  
Miao Zeng ◽  
Longkai Qi ◽  
Xiaocui Tang ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
Bacterial Strain ◽  
Brain Function ◽  
Intestinal Tract ◽  
High Fat ◽  
Indirect Methods ◽  
Neurotransmitter Secretion ◽  
Direct And Indirect Methods ◽  
Neurotransmitter Metabolism ◽  
Host Brain

AbstractGut microbiota (GM) metabolites can modulate the physiology of the host brain through the gut–brain axis. We wished to discover connections between the GM, neurotransmitters, and brain function using direct and indirect methods. A diet with increased amounts of sugar and fat (high-sugar and high-fat (HSHF) diet) was employed to disturb the host GM. Then, we monitored the effect on pathology, neurotransmitter metabolism, transcription, and brain circularRNAs (circRNAs) profiles in mice. Administration of a HSHF diet-induced dysbacteriosis, damaged the intestinal tract, changed the neurotransmitter metabolism in the intestine and brain, and then caused changes in brain function and circRNA profiles. The GM byproduct trimethylamine-n-oxide could degrade some circRNAs. The basal level of the GM decided the conversion rate of choline to trimethylamine-n-oxide. A change in the abundance of a single bacterial strain could influence neurotransmitter secretion. These findings suggest that a new link between metabolism, brain circRNAs, and GM. Our data could enlarge the “microbiome–transcriptome” linkage library and provide more information on the gut–brain axis. Hence, our findings could provide more information on the interplay between the gut and brain to aid the identification of potential therapeutic markers and mechanistic solutions to complex problems encountered in studies of pathology, toxicology, diet, and nutrition development.

The human intestinal tract – a hotbed of resistance gene transfer? Part I

2007 ◽  
Vol 29 (3) ◽  
pp. 17-21 ◽  
Author(s):  
Abigail A. Salyers ◽  
Kyung Moon ◽  
David Schlesinger
Keyword(s):  
Gene Transfer ◽  
Resistance Gene ◽  
Intestinal Tract ◽  
Human Intestinal Tract

scholarly journals From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?

2020 ◽  
Author(s):  
Giovanni Vitale ◽  
◽  
Alessandra Dicitore ◽  
Luigi Barrea ◽  
Emilia Sbardella ◽  
...  
Keyword(s):  
Immune System ◽  
Gut Microbiota ◽  
Intestinal Tract ◽  
Potential Role ◽  
Neuroendocrine Neoplasms ◽  
Complex Interplay ◽  
Barrier Integrity ◽  
Tumorigenesis And Progression ◽  
Intestinal Pathogens ◽  
Immune System Modulation

Abstract Gut microbiota is represented by different microorganisms that colonize the intestinal tract, mostly the large intestine, such as bacteria, fungi, archaea and viruses. The gut microbial balance has a key role in several functions. It modulates the host’s metabolism, maintains the gut barrier integrity, participates in the xenobiotics and drug metabolism, and acts as protection against gastro-intestinal pathogens through the host’s immune system modulation. The impaired gut microbiota, called dysbiosis, may be the result of an imbalance in this equilibrium and is linked with different diseases, including cancer. While most of the studies have focused on the association between microbiota and gastrointestinal adenocarcinomas, very little is known about gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs). In this review, we provide an overview concerning the complex interplay between gut microbiota and GEP NENs, focusing on the potential role in tumorigenesis and progression in these tumors.

Sign in / Sign up

Export Citation Format

Share Document